Cancer, Chemistry, and the Cell: Molecules that Interact with the Neurotensin Receptors

被引:69
作者
Myers, Rebecca M. [1 ]
Shearman, James W. [1 ]
Kitching, Matthew O. [1 ]
Ramos-Montoya, Antonio [2 ]
Neal, David E. [2 ]
Ley, Steven V. [1 ]
机构
[1] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
[2] CRUK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England
关键词
INFLAMMATORY-BOWEL-DISEASE; DRUG-DELIVERY SYSTEM; CYCLIC-GMP FORMATION; PROSTATE-CANCER; BREAST-CANCER; SORTILIN/NEUROTENSIN RECEPTOR-3; RAT NEUROTENSIN; HIGH-AFFINITY; IN-VITRO; FUNCTIONAL EXPRESSION;
D O I
10.1021/cb900038e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The literature covering neurotensin (NT) and its signalling pathways, receptors, and biological profile is complicated by the fact that the discovery of three NT receptor subtypes has come to light only In recent years. Moreover, a lot of this literature explores NT in the context of the central nervous system and behavioral studies. However, there is now good evidence that the up-regulation of NT is intimately involved in cancer development and progression. This Review aims to summarize the isolation, cloning, localization, and binding properties of the accepted receptor subtypes (NTR1, NTR2, and NTR3) and the molecules known to bind at these receptors. The growing role these targets are playing in cancer research is also. discussed. We hope this Review will provide a useful overview and a one-stop resource for new researchers engaged in this field at the chemistry-biology interface.
引用
收藏
页码:503 / 525
页数:23
相关论文
共 205 条
[1]  
Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO
[2]  
2-S
[3]   Neuroendocrine cells in tumour growth of the prostate [J].
Abrahamsson, PA .
ENDOCRINE-RELATED CANCER, 1999, 6 (04) :503-519
[4]   Solid lipid nanoparticles as a drug delivery system for peptides and proteins [J].
Almeida, Antonio J. ;
Souto, Eliana .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) :478-490
[5]   FATTY-ACIDS STEREOSPECIFICALLY STIMULATE NEUROTENSIN RELEASE AND INCREASE [CA2+]I IN ENTERIC ENDOCRINE-CELLS [J].
BARBER, DL ;
CACACE, AM ;
RAUCCI, DT ;
GANZ, MB .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (03) :G497-G503
[6]   Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1 [J].
Barroso, S ;
Richard, F ;
Nicolas-Ethève, D ;
Reversat, JL ;
Bernassau, JM ;
Kitabgi, P ;
Labbé-Jullié, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) :328-336
[7]  
BENDER D, 2008, NEUROIMAGE, V41, pT58
[8]  
Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO
[9]  
2-Z
[10]   Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain [J].
Betancur, C ;
Canton, M ;
Burgos, A ;
Labeeuw, B ;
Gully, D ;
Rostène, W ;
Pélaprat, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 343 (01) :67-77